Different dietary restriction regimens extend lifespan by both independent and overlapping genetic pathways in C. elegans.
Dietary restriction (DR) has the remarkable ability to extend lifespan and healthspan. A variety of DR regimens have been described in species ranging from yeast to mammals. However, whether different DR regimens extend lifespan via universal, distinct, or overlapping pathways is still an open question. Here we examine the genetic pathways that mediate longevity by different DR regimens in Caenorhabditis elegans. We have previously shown that the low-energy sensing AMP-activated protein kinase AMPK/aak-2 and the Forkhead transcription factor FoxO/daf-16 are necessary for longevity induced by a DR regimen that we developed (sDR). Here we find that AMPK and FoxO are necessary for longevity induced by another DR regimen, but are dispensable for the lifespan extension induced by two different DR methods. Intriguingly, AMPK is also necessary for the lifespan extension elicited by resveratrol, a natural polyphenol that mimics some aspects of DR. Conversely, we test if genes previously reported to mediate longevity by a variety of DR methods are necessary for sDR-induced longevity. Although clk-1, a gene involved in ubiquinone biosynthesis, is also required for sDR-induced lifespan extension, we find that four other genes (sir-2.1, FoxA/pha-4, skn-1, and hsf-1) are all dispensable for longevity induced by sDR. Consistent with the observation that different DR methods extend lifespan by mostly independent genetic mechanisms, we find that the effects on lifespan of two different DR regimens are additive. Understanding the genetic network by which different DR regimens extend lifespan has important implications for harnessing the full benefits of DR on lifespan and healthspan.
Greer
Eric L
EL
Department of Genetics, Stanford University, Stanford, CA 94305, USA.
Brunet
Anne
A
D000091162:AMP-Activated Protein Kinase Kinases; D000818:Animals; D000975:Antioxidants / Q000494:pharmacology; D017173:Caenorhabditis elegans / Q000235:genetics* / Q000378:metabolism*; D029742:Caenorhabditis elegans Proteins / Q000378:metabolism; D031204:Caloric Restriction / Q000379:methods*; D004268:DNA-Binding Proteins / Q000378:metabolism; D005508:Food Deprivation / Q000502:physiology*; D005526:Food, Formulated; D051858:Forkhead Transcription Factors / Q000378:metabolism; D005786:Gene Expression Regulation / Q000187:drug effects / Q000502:physiology; D008136:Longevity / Q000187:drug effects / Q000502:physiology*; D011494:Protein Kinases / Q000378:metabolism; D000077185:Resveratrol; D015398:Signal Transduction / Q000187:drug effects / Q000235:genetics*; D037761:Sirtuins / Q000378:metabolism; D013267:Stilbenes / Q000494:pharmacology; D015534:Trans-Activators / Q000378:metabolism; D014157:Transcription Factors / Q000378:metabolism
D000975:Antioxidants; D029742:Caenorhabditis elegans Proteins; D004268:DNA-Binding Proteins; D051858:Forkhead Transcription Factors; C113277:Pha-4 protein, C elegans; D013267:Stilbenes; D015534:Trans-Activators; D014157:Transcription Factors; C474710:heat shock factor-1, C elegans; C073702:skn-1 protein, C elegans; D011494:Protein Kinases; D000091162:AMP-Activated Protein Kinase Kinases; C507014:SIR-2.1 protein, C elegans; D037761:Sirtuins; D000077185:Resveratrol